Activity value 75International Buyer&Supplier,Last transaction date:
2022-11-16Address: 35 avenue du gros chene zi des bellevues 95220 herblay
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for g pharma from 2021 to 2022.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2022, the company has completed 1 transactions, with a transaction quantity of 100 and a transaction weight of 14.2.
YearTransactionsQuantityWeight
2021000
2022110014.2
Bill of lading data
<
1/2
>
Trade date
2022/11/16
B/L No.
22341453ex00302988
Suppliers
silver pharma ecza deposu as
Buyers
g pharma
POLs
istanbul havalimani
PODs
——
Supply area
Turkey
Purchas area
Singapore
Weight
14.2kg
Amount
18710
Hs code
300490000000
Product tags
——
Product description
DIĞERLERI
Expand
Trade date
2011/01/27
B/L No.
——
Suppliers
——
Buyers
g pharma
POLs
——
PODs
——
Supply area
——
Purchas area
France
Weight
——
Amount
——
Hs code
Product tags
——
Product description
FABRICATION D'AUTRES PRODUITS PHARMACEUTIQUES
Expand
g pharma is International Buyer&Supplier,
According to the 52wmb.com global trade database, as of 2022-11-16, the company has completed 68 international trades,
with its main trading regions covering turkey etc.
The core products include HS300490000000 etc,
and its main trading partners are silver pharma ecza deposu as.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on g pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.